CytomX Therapeutics, Inc. (CTMX)
4.54
-0.24
(-5.02%)
USD |
NASDAQ |
Mar 20, 10:25
CytomX Therapeutics Profit Margin (Quarterly) : -4.00K% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| REGENXBIO, Inc. | -221.3% |
| ACADIA Pharmaceuticals, Inc. | 96.33% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| Savara, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | -5.20% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -24.75% |
| Return on Assets | -12.28% |
| Return on Invested Capital | -22.55% |
| Gross Profit Margin (Quarterly) | 23.08% |
| Operating Margin (Quarterly) | -4.21K% |
| Return on Net Operating Assets | -152.7% |